Prolonged exposure to increased plasma glucocorticoid levels in later life promotes the loss of hippocampal neurons, disrupts hippocampal electrophysiology, and contributes to cognitive deficits. In the aged rat (and probably in humans) chronically elevated glucocorticoid levels derive from dysfunction within the hypothalamic-pituitary-adrenal (HPA) axis, notably from inefficient corticosteroid negative feedback regulation. This condition results in increased corticotropin-releasing hormone (CRH) synthesis in the hypothalamic neurons which regulate pituitary ASH release. In aged rats increased HPA activity selectively associated with hippocampal pathology, and neither are an inevitable consequence of aging. In the first part of this proposal were are examining the neurobiological mechanisms for such individual differences in HPA activity in later life. Our focus is on 1) hypothalamic CRH gene expression and 2) glucocorticoid negative feedback sensitivity in aged- impaired vs. aged-unimpaired rats. In the second part of the proposal we are examining the effects of various antidepressant drugs treatments on HPA function in aged rats. These studies derive from earlier research in young animals and our initial studies where we showed that HPA dysfunction in the aged, cognitive-impaired rat is reversed with chronic desipramine treatment. We propose to test the idea that longterm antidepressant drug treatment might serve to 1) increase corticosteroid negative-feedback efficiency by increasing corticosteroid receptor biosynthesis in certain critical brain regions known to regulate HPA activity, 2) to reduce hypothalamic CRH synthesis and release, 3) thus to reduce HPA hyperactivity in aged rats, and 4) to attenuate hippocampal pathology in later life. The studies in this section will examine the effects of antidepressant drug treatment on hypothalamic CRH mRNA expression, corticosteroid receptor mRNA and binding levels in various brain regions and pituitary, and glucocorticoid feedback sensitivity. Further studies are designed to examine both the short term and long-term consequences for hippocampal function of reducing HPA activity in aging animals, including a populations of animals that can be considered at """"""""high risk"""""""" for the development of age-related hippocampal pathology. It is becoming increasingly apparent that age-related forms of neuropathology emerge in response to a number of events, some unquestionably associated with the genome, others epigenetic in origin. Whether such epigenetic factors, such as endocrine responses to stress contribute to the development of Alzheimer's disease (or other forms of clinical dementia) remains to be determined. However, from what we know of the disease process and the brain structures most affected (e.g., hippocampus), it seems infinitely reasonable that chronic exposure to """"""""stress hormones"""""""" such as the glucocorticoids can influence the seventy of symptoms and the progression of the disorder. On the basis of our recent findings, we feel that 1) we have a very relevant target for therapeutic intervention (the neural glucocorticoid receptor system and feedback sensitivity) and 2) a potentially very useful tool (antidepressant drugs) with which to study potentially effective interventions (be they some form of antidepressant or other treatments). Although the focus here is on neurological aging, chronically increased glucocorticoid levels can also contribute to the onset of diabetes and hypertension, both prevalent amongst the elderly. Thus the saliency of this research extends beyond that of brain aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG009488-04A1
Application #
2050846
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1995-09-30
Project End
1998-08-31
Budget Start
1995-09-30
Budget End
1996-08-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Mcgill University
Department
Type
DUNS #
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 0-G4
Lupien, S J; Nair, N P; Briere, S et al. (1999) Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 10:117-39
Lupien, S J; de Leon, M; de Santi, S et al. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1:69-73
Rowe, W; Steverman, A; Walker, M et al. (1997) Antidepressants restore hypothalamic-pituitary-adrenal feedback function in aged, cognitively-impaired rats. Neurobiol Aging 18:527-33
Kuchel, G A; Rowe, W; Meaney, M J et al. (1997) Neurotrophin receptor and tyrosine hydroxylase gene expression in aged sympathetic neurons. Neurobiol Aging 18:67-79
Viau, V; Sharma, S; Meaney, M J (1996) Changes in plasma adrenocorticotropin, corticosterone, corticosteroid-binding globulin, and hippocampal glucocorticoid receptor occupancy/translocation in rat pups in response to stress. J Neuroendocrinol 8:1-8
Sarrieau, A; O'Donnell, D; Alonso, R et al. (1996) Regulation of glucocorticosteroid receptor expression in rat hippocampal cell cultures by nerve growth factor. Neurosci Lett 206:207-11
Parent, A; Rowe, W; Meaney, M J et al. (1995) Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. J Pharmacol Exp Ther 272:1110-6
Bodnoff, S R; Humphreys, A G; Lehman, J C et al. (1995) Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 15:61-9
Lupien, S; Lecours, A R; Lussier, I et al. (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-903
Meaney, M J; Bhatnagar, S; Diorio, J et al. (1993) Molecular basis for the development of individual differences in the hypothalamic-pituitary-adrenal stress response. Cell Mol Neurobiol 13:321-47

Showing the most recent 10 out of 11 publications